An overview of the Randox Cardiac Risk Prediction Array, a molecular assay utilising innovative biochip array technology (BAT) to simultaneously genotype 19 SNPs associated with coronary heart disease for comprehensive genetic risk assessment, including a dedicated SNP to predict response to statin treatment, for reliable patient genotyping within one day.
DiagnosticsGenomicsMicrofluidicsProteomics and Metabolomics